NuVisio® is a biotechnology research and development spin out company from the University of Nottingham. NuVision® aims to develop innovative high quality and cost effective ophthalmology and wound care regenerative therapies.
Location: United States, West Virginia, Nottingham
Employees: 11-50
Phone: +44 115 784 0120
Total raised: $3.76M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | BioCity | biocity.co... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 09.03.2023 | - | $1.31M | Midlands E... |
| 13.09.2019 | - | $1.75M | - |
| 13.02.2018 | - | $700.76K | - |
Mentions in press and media 11
| Date | Title | Description |
| 09.03.2023 | NuVision bags £1.1m funding for placenta-based healing contact lens | Nottingham-based health tech company NuVision has scooped £1.1m in funding for its wound dressing and contact lenses that use the inner layer of the placenta to heal eye injuries. Healthcare providers including the NHS use NuVision’s wound ... |
| 09.03.2023 | Biotech firm with product to help heal eye conditions raises £1m | NuVision – a Nottingham-based company with a product that speeds up healing of eye conditions – has raised a further £1.1m investment. |
| 09.03.2023 | NuVision Raises Further £1.1M in Funding | NuVision, a Nottingham, UK-based company with a product that speeds up healing of eye conditions, raised £1.1M in further funding. The round, which brings the total raised by the company to over £5M, was led by MEIF Proof of Concept & E... |
| 16.07.2021 | Mercia Asset Management : Biotech firm that ‘could revolutionise woundcare' raises £1.8m | A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m. Nottingham-based NuVision Biotherapies has secured funding from the MEIF Proof of Concept & E... |
| 16.07.2021 | Biotech firm that ‘could revolutionise woundcare’ raises £1.8m | A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m. |
| 16.07.2021 | Nottingham’s biotech secures £1.8M funding for groundbreaking wound healing technology | A biotech company based in Nottingham – NuVision Biotherapies has come up with a product, which helps to heal eye injuries efficiently and wants to revolutionise the treatment of other wounds. The company recently picked up £1.8 million fun... |
| 13.09.2019 | NuVision Biotherapies Raises £1.4m in Funding | NuVision Biotherapies, a UK-based regenerative medicine company, raised £1.4m in funding. The funding came from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund; Me... |
| 09.02.2018 | £500k investment will help woundcare company follow its vision | A Nottingham regenerative medicine company which has developed a groundbreaking therapy that can help prevent sight loss has completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham... |
| 08.02.2018 | NuVision Biotherapies Raises £500K in Funding | NuVision Biotherapies, a Nottingham, UK-based regenerative medicine company, raised £500k in funding. Backers included Mercia Fund Managers, angel investors and the University of Nottingham. The company intends to use the funds to further d... |
| 28.07.2015 | NuVision becomes first University of Nottingham spinout to receive seed funding from Mercia | Mercia Fund Management (MFM), a national fund management business with a focus on the Midlands, North and Scotland, has committed £379,000 in seed funding to NuVision Biotherapies Ltd, a University of Nottingham spinout developing effective... |
Show more